A detailed history of Rafferty Asset Management, LLC transactions in Liquidia Corp stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 11,323 shares of LQDA stock, worth $130,554. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,323
Previous 11,841 4.37%
Holding current value
$130,554
Previous $142,000 20.42%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$8.9 - $14.11 $4,610 - $7,308
-518 Reduced 4.37%
11,323 $113,000
Q2 2024

Aug 13, 2024

BUY
$11.96 - $15.71 $141,618 - $186,022
11,841 New
11,841 $142,000
Q3 2022

Nov 14, 2022

BUY
$3.73 - $8.39 $40,418 - $90,914
10,836 New
10,836 $59,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $742M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.